1. Home
  2. TENX vs GIPR Comparison

TENX vs GIPR Comparison

Compare TENX & GIPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

SELL

Current Price

$1.42

Market Cap

73.8M

Sector

Health Care

ML Signal

SELL

Logo Generation Income Properties Inc.

GIPR

Generation Income Properties Inc.

SELL

Current Price

$0.30

Market Cap

808.1K

Sector

Real Estate

ML Signal

SELL

Company Overview

Basic Information
Metric
TENX
GIPR
Founded
1967
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
73.8M
808.1K
IPO Year
2001
2015

Fundamental Metrics

Financial Performance
Metric
TENX
GIPR
Price
$1.42
$0.30
Analyst Decision
Buy
Analyst Count
10
0
Target Price
★ $10.29
N/A
AVG Volume (30 Days)
1.4M
★ 2.4M
Earning Date
11-05-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $9,739,942.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.31
$0.11
52 Week High
$19.40
$1.76

Technical Indicators

Market Signals
Indicator
TENX
GIPR
Relative Strength Index (RSI) 32.89 44.25
Support Level $1.34 $0.24
Resistance Level $2.01 $0.28
Average True Range (ATR) 0.13 0.05
MACD -0.00 0.00
Stochastic Oscillator 1.64 66.32

Price Performance

Historical Comparison
TENX
GIPR

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

About GIPR Generation Income Properties Inc.

Generation Income Properties Inc is an internally managed real estate investment trust focused on acquiring and managing income-producing retail, office, and industrial properties net leased to high-quality tenants in different states throughout the United States. Its key source of revenue is the rental income. The trust's properties are generally net leased to a single tenant.

Share on Social Networks: